Regeneron Pharmaceuticals’s Adverum Biotechnologies ADVM Stock Holding History

Regeneron Pharmaceuticals’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-180,909	Closed	-$820K	–	3
2025 Q3	$820K	Hold	180,909	–	–	0.12%	3
2025 Q2	$389K	Hold	180,909	–	–	0.03%	4
2025 Q1	$791K	Hold	180,909	–	–	0.06%	4
2024 Q4	$845K	Buy	+180,909	New	+$1.22M	0.08%	5

Regeneron Pharmaceuticals's ADVM Position: Q4 2025 in Review

Regeneron Pharmaceuticals sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 180,909 shares — an estimated $820K sold.

Regeneron Pharmaceuticals first reported a position in ADVM in Q4 2024 and held it in 4 quarters. The position peaked at $845K in Q4 2024. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.

Regeneron Pharmaceuticals reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
Regeneron Pharmaceuticals sold 180,909 Adverum Biotechnologies shares in Q4 2025, an estimated $820K.
Regeneron Pharmaceuticals first reported a position in Adverum Biotechnologies in Q4 2024 and held it in 4 quarters.
Regeneron Pharmaceuticals's Adverum Biotechnologies position peaked at $845K in Q4 2024.
0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.

Based on Regeneron Pharmaceuticals's 13F filing for Q4 2025, filed 6 Feb 2026.